Egis Pharmaceuticals PLC

Egis Pharmaceuticals is a leading Central Eastern European generic pharmaceutical company with over 110 years of history. The company operates across the entire pharmaceutical value chain, from R&D and active ingredient (API) manufacturing to the production of finished dosage forms and international marketing in over 100 countries. Egis is a member of the Servier Group, a French-based international pharmaceutical company governed by a non-profit foundation. The company focuses primarily on cardiovascular and central nervous system (CNS) therapies, while also maintaining a strong presence in diabetology, dermatology, and wound care. In recent years, Egis has expanded its business model to include contract development and manufacturing services (CDMO) for small molecule drug substances.